BiotechTube
Home/Adrenomed/David Germonpré, MSc/Executive MBA
DG

David Germonpré, MSc/Executive MBA

Chief Financial Officer (CFO)

Adrenomed

Therapeutic Areas

SepsisSeptic ShockCritical Care

Adrenomed Pipeline

DrugIndicationPhase
Enibarcimab (Adrecizumab)Septic ShockPhase 2

Leadership Team at Adrenomed

DR
Dr. Richard Jones
Chief Executive Officer (CEO)
DS
Dr. Stephan Witte
Chief Medical Officer (CMO)
View full Adrenomed profile